Navigation Links
Closed Drug Transfer Systems: Oncology Therapeutics Market Dynamics and Closed Drug Transfer Design Factors - Market Forecasts to 2017
Date:6/6/2013

DUBLIN, June 6, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/qs2bc8/closed_drug) has announced the addition of the "Closed Drug Transfer Systems. Therapeutic Markets, Strategies and Outlook" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The administration of drugs deemed hazardous to humans has been receiving increasing amounts of scrutiny in recent years as the dangers of these substances become more clearly understood.

For caregivers and their patients, the therapeutic area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that - in spite of promising new drugs based on therapeutic antibodies - continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites, to treat a wide range of cancers. Regulatory and industry efforts to create standards and procedures designed to protect workers and patients from accidental and incidental exposure to cytotoxics are being driven by data that suggests a causal link between exposure and health issues. Studies of nurses who work with cytotoxic drugs on a regular basis have found a statistically higher rate of spontaneous abortion.

Several companies are responding to this unmet need by commercializing devices for closed transfer of these drugs. As the market evolves and user acceptance increases, so too will the impact of these products on oncology therapy protocols and drug delivery.

Highlights

- Analyzes the impact of drug toxicity and safety factors on therapeutic oncology market segments, market dynamics and market demographics

- Provides detailed analysis of closed drug transfer products for the handing of cytotoxic drugs

- Analyzes demand drivers and competitive factors influencing closed drug transfer adoption

- Charts product data and provides forecasts to 2017

- Profiles closed drug transfer device participants, their product development activities, business strategies, and corporate alliances and affiliations

Key Topics Covered:

Executive Summary

Oncology Therapeutics Market Dynamics 

Therapeutic Trends and Issues
The Administration of injectable/Infusable Antineoplastics
Drug Packaging and Administration Technology
Closed Drug Transfer Market Drivers
Competitive Landscape
Risk Factors

Closed Drug Transfer Design Factors

Key System Design Elements
Human Engineering/Ergonomics
Material Selection Issues
Drug Reconstitution and Dilution
Oncology Therapeutics Medication Safety
Oncology Drug Administration and Dosing
Drug-Specific Dosing Modification and Individualized Dosing

Closed Drug Transfer - Commercial Device Assessments and Market Data 

Market Factors

Regulatory Issues
Caregiver Compliance
Level of Complexity and Ease of Use
Healthcare Economics
Business Models and Strategies

Market Assessments and Forecasts

North America
Europe
Asia
Other Geographic Markets

Closed Drug Transfer - Market Participant Profiles

For more information visit http://www.researchandmarkets.com/research/qs2bc8/closed_drug

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Aesthetics Pharmaceutical Company Selects 360 Vantage Closed Loop Marketing Solution for Apple iPad
2. BellBrook Labs Launches Four New Turn-Key Methyltransferase Assay Kits
3. The Research Foundation for The State University of New York Enters Site License Agreement with 2Market Information Inc., Publisher of Technology Transfer Tactics
4. BellBrook Labs and BMG Labtech to Offer Webinar on Integrated Platform for Screening Kinases and Methyltransferases
5. Cyber Infrastructure Pvt. Ltd. (CIS) Begins Offering BOT (Build-Operate-Transfer) IT-Outsourcing Model for SMEs
6. Susterra® Propanediol Used in Greenway® Solar Heat Transfer Fluids
7. Nature Materials study: Boosting heat transfer with nanoglue
8. Physicists skirt thermal vibration, transfer optical signal via mechanical oscillator
9. Scientists target bacterial transfer of resistance genes
10. Ambit Announces Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the Annual Meeting of the American Society of Clinical Oncology
11. AbbVie Presents Results from Phase I Study of Investigational Oncology Compound ABT-199 at American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global contract research, ... improve patient outcomes and quality of life, will now be offering its impurity ... to new regulatory requirements for all new drug products, including the finalization of ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its ... 2018 in San Francisco, CA. The Summit brings together current and former FDA office ... directors and government officials from around the world to address key issues in device ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... maternal age to IVF success. , After comparing the results from the fresh ...
(Date:10/10/2017)... Poway, California (PRWEB) , ... October 10, 2017 , ... ... afternoon speaking at his local San Diego Rotary Club. The event ... San Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/30/2017)... The research team of The Hong Kong ... identification by adopting ground breaking 3D fingerprint minutiae recovery and matching ... and accuracy for use in identification, crime investigation, immigration control, security ... ... A research team led by ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):